Current
Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022
MMWR, September 30, 2022, 71 (2); 1-8
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
-
PPSV (Pneumococcal Polysaccharide)
Current
Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.
MMWR. 2023 / 72(RR-3);1–39
Current
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2024–25 Influenza Season
MMWR: August 29, 2024;73(No. RR-5):1–25
Current
Interim Infection Prevention and Control Recommendations for Measles in Healthcare Settings
CDC Infection Control Guideline Library - July 2019
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
Current
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR, January 28, 2022, 71 (4); 109-117
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
Current
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
MMWR September 12, 2024 / 73(36);793–798
-
TBE (Tick-Borne Encephalitis)
Current
Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
MMWR November 10, 2023 / 72(5);1–29
Archived
Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
MMWR, April 25, 2024 / 73(16);377–381
Archived
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2024
MMWR, January 11, 2024, 73(1); 6-10
Archived
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2024
MMWR, January 11, 2024, 73(1); 11-15
Archived
Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023
MMWR: October 20, 2023 / 72(42);1140–1146
Archived
COVID-19 Vaccination Recommendations and Practices for Women of Reproductive Age by Health Care Providers — Fall DocStyles Survey, United States, 2022
MMWR: September 29, 2023 / 72(39);1045–1051
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023–24 Influenza Season
MMWR; August 25, 2023;72(RR-2);1-25
Archived
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023
MMWR: June 16, 2023 / 72(24);657–662
Archived
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2023
MMWR, February 10, 2023, 72(6); 137-140
Archived
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2023
MMWR, February 10, 2023, 72(6); 141-144
Archived
ACIP Interim Recommendations for the Use of Bivalent Booster Doses of COVID-19 Vaccines—United States, October 2022
MMWR, November 11, 2022, 71(45);1436-1441
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2022–23 Influenza Season
MMWR, August 26, 2022, 71(1); 1-28
Archived
ACIP Interim Recommendation for Use of the Novavax COVID-19 Vaccine in Adults 18 years and older — US, July 2022
MMWR, August 5, 2022, 71(31);988–992
Archived
ACIP Interim Recommendations for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022
MMWR Early Release June 28, 2022
Archived
ACIP Recommendation for use of Moderna COVID-19 Vaccine in Adults aged 18 years and older, considerations for extended intervals for primary series doses of mRNA COVID-19 vaccines — US, February 2022
MMWR, March 18, 2022, 71 (11); 416-421
Archived
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022
MMWR, February 18, 2022, 71(7); 229-233
Archived
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022
MMWR, February 18, 2022, 71(7); 234-237
Archived
ACIP Updated Interim Recommendations for Use of the Janssen (Johnson & Johnson) COVID-19 vaccine, US, December 2021
MMWR, January 21, 2022, 71(3);90-95
Archived
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years - US, 2021
MMWR Early Release, November 5, 2021, 70
Archived
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged 16 Years and older: Recommendations of the Advisory Committee on Immunization Practices — U.S., September 2021
MMWR Early Release, September 21, 2021
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2021–22 Influenza Season
MMWR, August 27, 2021, 70(5); 1–28
Archived
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from ACIP — US, July 2021
MMWR, August 13, 2021, 70(32);1094-1099
Archived
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from ACIP — US, June 2021
MMWR Early Release, July 6, 2021
Archived
ACIP Interim Recommendations for use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 years, US, May 2021
MMWR Early Release, May 14, 2021, 70
Archived
Updated Recommendation from ACIP for Use of Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — U.S. April 2021
MMWR Early Release, April 27, 2021, 70
Archived
ACIP Interim Recommendation for Use of Janssen (Johnson and Johnson) COVID-19 Vaccine - U.S., February 2021
MMWR, March 2, 2021, 70
Archived
ACIP Updated Interim Recommendation for Allocation of COVID-19 Vaccine – U.S., December 2020
MMWR, December 22, 2020, 69
Archived
ACIP Interim Recommendation for Use of Moderna COVID-19 Vaccine – U.S, December 2020
MMWR, December 20, 2020, 69
Archived
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine – U.S., December 2020
MMWR, December 13, 2020, 69
Archived
ACIP Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine – U.S., 2020
MMWR, December 3, 2020, 69
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 Influenza Season
MMWR, August 21, 2020, 69 (8); 1–24
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season
MMWR, August 23, 2019, 68(3); 1–21
Archived
Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness
MMWR, February 15, 2019; 68(6);153–156
Archived
Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel
MMWR, November 2, 2018; 67(43);1216–1220
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2018–19 Influenza Season
MMWR, August 24, 2018, 67(3); 1-20
Archived
Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
MMWR, June 8, 2018; 67 (22); 643–645
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season
MMWR, August 25, 2017, 66(2); 1–20
Archived
Updated Recommendations for Use of MenB-FHbp Serogroup B (Trumenba) Meningococcal Vaccine
MMWR, May 19, 2017; 66(19); 509-513
Archived
Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons – Advisory Committee on Immunization Practices (ACIP), 2016
MMWR, November 4, 2016, Vol. 65(43);1189–1194
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2016–17 Influenza Season
MMWR, August 26, 2016, Vol. 65(5):1-54
Archived
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
MMWR, October 23, 2015; 64(41)1171–1176
Archived
Update: Shortened Interval for Postvaccination Serologic Testing of Infants Born to Hepatitis B-Infected Mothers
MMWR, October 9, 2015; 64(39):1118-20
Archived
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season
MMWR, August 7, 2015; 64(30):818-825
Archived
Use of Serogroup B Meningococcal Vaccines in Persons Aged >10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
MMWR, June 12, 2015; 64(22);608-612
Current
Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies
MMWR, March 19, 2010; 59(02):1-9
Archived
Update on Recommendations for Use of Herpes Zoster Vaccine
MMWR, August 22, 2014; 63(33):729-731
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2014–2015
MMWR, August 15, 2014; 63(327):691–697
Archived
Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease
MMWR, June 20, 2014; 63(24):527-530
Archived
CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management – Recommendations and Reports
MMWR, December 20, 2013; 62(rr10);1-19 (Not an ACIP statement but an important document from CDC.)
-
Japanese Encephalitis (JE)
Archived
Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
MMWR, November 15, 2013; 62(45):898-900
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
MMWR, September 20, 2013; 62(RR–7):1-48
Archived
Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013 Weekly
MMWR, May 10, 2013; 62(18):356
Archived
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, March 22, 2013; 62(RR02):1-22
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP)
MMWR, February 22, 2013;62(07):131-5
Archived
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
MMWR, January 25, 2013; 62(3):52-4
Archived
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13 Influenza Season
MMWR, August 18, 2012;61(32);613-8
Archived
Updated CDC Recommendations for the Management of Hepatitis B Virus–Infected Health-Care Providers and Students
MMWR, July 6, 2012; 61(RR03):1-12
Archived
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
MMWR, June 1, 2012; 61(21):394-5
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
MMWR, June 29, 2012; 61(25):468-70
